Valuation: Arkema

Market Cap 4.33B 4.82B 3.99B 3.62B 6.85B 452B 7.04B 47.73B 19.02B 242B 18.1B 17.72B 766B P/E 2026 *
19.5x
P/E 2027 * 15x
Enterprise Value 6.83B 7.62B 6.3B 5.72B 10.82B 714B 11.12B 75.38B 30.03B 383B 28.59B 27.98B 1,210B EV / Sales 2026 *
0.75x
EV / Sales 2027 * 0.71x
Free-Float
90.49%
Yield 2026 *
6.27%
Yield 2027 * 6.41%
1 day+0.96%
1 week+2.39%
Current month+3.21%
1 month+6.54%
3 months-6.47%
6 months-11.27%
Current year+10.93%
1 week 56.15
Extreme 56.15
60.05
1 month 53.95
Extreme 53.95
60.05
Current year 48.3
Extreme 48.3
67.05
1 year 48.3
Extreme 48.3
67.05
3 years 48.3
Extreme 48.3
104.4
5 years 48.3
Extreme 48.3
134.95
10 years 42.5
Extreme 42.5
134.95
Manager TitleAgeSince
Chief Executive Officer 63 06/03/2006
Director of Finance/CFO 55 01/06/2018
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 63 06/03/2006
Director/Board Member 57 01/01/2014
Director/Board Member 62 01/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
10/15/26 A
ISALT-Investissements Stratégiques en Actions Long Terme SASU
SellCompany -45,008 0.0592%
10/15/26 A
ISALT-Investissements Stratégiques en Actions Long Terme SASU
SellCompany -20,000 0.0263%
10/14/26 A
ISALT-Investissements Stratégiques en Actions Long Terme SASU
SellCompany -9,751 0.0128%
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+2.39%+12.22%-36.01% 4.85B
+0.14%+0.99%+19.01%+72.97% 86.03B
-0.42%+2.48%+20.08%+27.30% 45.69B
+1.38%+5.98%+27.42%-13.78% 37.38B
+4.37%+7.88%+19.97%+23.56% 35.59B
-3.42%-3.82%+6.64%+28.30% 31.83B
+3.55%-0.03%+2.03%+20.56% 25.35B
+0.30%-1.65%+53.82%+37.73% 23.74B
+0.34%+1.49%+29.02%-24.47% 20.56B
-3.54%+1.55%+5.14%+16.38% 16.2B
Average +0.37%+1.43%+19.53%+15.25% 33B
Weighted average by Cap. +0.49%+1.02%+20.07%+29.81%

Financials

2026 *2027 *
Net sales 9.11B 10.16B 8.4B 7.63B 14.44B 953B 14.84B 101B 40.07B 510B 38.14B 37.33B 1,614B 9.35B 10.43B 8.62B 7.83B 14.82B 978B 15.23B 103B 41.12B 524B 39.14B 38.31B 1,656B
Net income 254M 283M 234M 212M 402M 26.54B 413M 2.8B 1.12B 14.22B 1.06B 1.04B 44.95B 388M 432M 357M 324M 614M 40.52B 631M 4.28B 1.7B 21.71B 1.62B 1.59B 68.63B
Net Debt 2.51B 2.79B 2.31B 2.1B 3.97B 262B 4.08B 27.65B 11.02B 140B 10.49B 10.26B 444B 2.32B 2.59B 2.14B 1.94B 3.68B 243B 3.78B 25.64B 10.22B 130B 9.72B 9.52B 411B
Projected Income Statement - Annual - Arkema
Logo Arkema
Arkema is one of the world's leaders in the development, manufacturing and marketing of chemical products. Net sales break down by family of products as follows: - advanced materials (38%): high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, etc.; - adhesives (30.2%): sealants, adhesives for floors and tiles, waterproofing products, etc.; - coating solutions (24%): resins, emulsions for adhesives, surface coating products, absorbents, etc.; - intermediate products (7.5%): thermoplastic polymers (PMMA), acrylic products, fluorinated gases, etc.; - other (0.3%). At the end of 2025, the group had 151 production sites worldwide. Net sales are distributed geographically as follows: France (7.2%), Europe (25.4%), the United States (30.6%), China (13.5%), Asia (14.4%), Canada and Mexico (3.6%), and Other (5.3%).
Employees
20,700
Date Price Change Volume
10/11/26 €57.85 +0.96% 126,152
09/11/26 €57.30 -0.61% 200,671
06/11/26 €57.65 -2.04% 234,720
05/11/26 €58.85 +1.73% 239,822
04/11/26 €57.85 +2.39% 230,696
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Arkema
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
57.30EUR
Average target price
62.54EUR
Spread / Average Target
+9.14%